Fluoroquinolone-induced motor changes in the guinea-pig isolated ileum

Pharmacology and Toxicology

Volumn 83, Issue 6, 1998, Pages 263-269

  Di Nucci, Amalia ^a   Candura, Stefano M ^a   Tagliani, Monica ^a   D'Agostino, Gianluigi ^a   Spelta, Valeria ^a   Fiori, Enrico ^a   Ricotti, Paoła ^a   Tonini, Marcello ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPANE SULPHONIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; APAMIN; ENOXACIN; INDOMETACIN; KETOPROFEN; N(G) NITROARGININE; NORFLOXACIN; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCOPOLAMINE; SURAMIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL MOTILITY; GUINEA PIG; ILEUM MUCOSA; INTESTINE CONTRACTION; MALE; MOTOR ACTIVITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0031742547     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01480.x     Document Type: Article

References (46)

1. Abrahamsson, H.: Studies on the inhibitory nervous control of gastric motility. Acta physiol. scand. 1973, 390, 1-38.
2. Akahane, K., M. Sekiguchi, T. Une & Y. Osada: Structure-epileptogenicity relationship of quinolones with special reference to the interaction with γ-aminobutyric acid receptor sites. Antimicrob. Agents Chemother. 1989, 33, 1704-1708.
3. Akahane, K., Y. Kimura, Y. Tsutomi & I. Hayakawa: Possible inter-molecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Antimicrob. Agents Chemother. 1994, 38, 2323-2329.
4. A receptor in dissociated hippocampal cells of rat. J. Neurophysiol. 1991, 66, 497-504.
5. A receptor-mediated stimulation of gastric acid secretion and intestinal motility. Eur. J. Pharmacol. 1991, 201, 35-39.
6. Brown, C. M. & G. Burnstock: The structural conformation of the polyphosphate chain of the ATP molecule is critical for its promotion of prostaglandin biosynthesis. Eur. J. Pharmacol. 1981, 69, 81-86.
7. Burnstock, G., T. Cocks, B. Paddle & J. Staszewska-Barczak: Evidence that prostaglandin is responsible for the 'rebound contraction' following stimulation of non-adrenergic, non-cholinergic ('purinergic') nerves. Eur. J. Pharmacol. 1975, 31, 360-362.
8. Ciccocioppo, R., L. Onori, E. Messori, S. M. Candura, T. Coccini & M. Tonini: Role of nitric oxide-dependent and -independent mechanisms in peristalsis and accommodation in the rabbit distal colon. J. Pharmacol. Exp. Therap. 1994, 270, 929-937.
9. Crema, A., G. M. Frigo & S. Lecchini: A pharmacological analysis of the peristaltic reflex in the isolated colon of the guinea-pig or cat. Brit. J. Pharmacol. 1970, 39, 334-345.
10. Focaccio, A., G. Peeters, M. Movsesian, R. Roden, Y. Eki, J. Krall & M. R. Bristow: Mechanism of action of OPC-8490 in human ventricular myocardium. Circulation 1996, 93, 817-825.
11. Furness, J. B. & M. Costa: The participation of enteric inhibitory nerves in accomodation of the intestine to distension. Clin. Exp. Pharmacol. Physiol. 1977, 4, 37-41.
12. Furness, J. B., D. C. Trussel, S. Pompolo, J. C. Bornstein, B. E. Maley & J. Storm-Mathisen: Shapes and projections of neurons with immunoreactivity for γ-aminobutyric acid in the guinea-pig small intestine. Cell Tissue Res. 1989, 256, 293-301.
13. B receptor mediated effects in guinea-pig ileum. Brit. J. Pharmacol. 1983, 78, 469-478.
14. Grider, J. R. & G. M. Makhlouf: Colonie peristaltic reflex: Identification of vasoactive intestinal peptide as mediator of descending relaxation. Amer. J. Physiol. 1986, 251, G40-G45.
15. A and ionotropic glutamate receptors. Neuropharmacology 1995, 34, 1615-1624.
16. Hayball, P. J., R. L. Nation & F. Bochner: Enantioselective pharmacodynamics of nonsteroideal antinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity. Chirality 1992, 4, 484-487.
17. Hoyle, C. H. V. & G. Burnstock: Neuromuscular transmission in the gastrointestinal tract. In: Handbook of physiology. The gastrointestinal system. Motility and circulation. Ed.: J. D. Wood. American Physiological Society, Bethesda, Maryland (USA) 1989, pp. 435-464.
18. Kamikawa, Y., K. Serizawa & Y. Shimo: Some possibilities for prostaglandin mediation in the contractile response to ATP of the guinea-pig digestive tract. Eur. J. Pharmacol. 1977, 45, 199-203.
19. Kaplita, P. V., D. H. Waters & D. J. Triggle: γ-Aminobutyric acid action in guinea-pig myenteric plexus. Eur. J. Pharmacol. 1982, 79, 43-51.
20. Kawakami, J., K. Yamamoto, A. Asanuma, K. Yanagisawa, Y. Sawada & T. Iga: Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo. Toxicol. April. Pharmacol. 1997, 145, 246-254.
21. Kojima, H., M. Hirohashi, T. Sakurai, Y. Kasai & A. Akashi: General pharmacology of DL-8280. Chemotherapy 1984, 32 (suppl. 1), 1148-1161.
22. Lietman, P. S.: Fluoroquinolone toxicities. Drugs 1995, 49 (suppl. 2), 159-163.
23. Mann, P. T., B. R. Southwell, H. M. Young & J. B. Furness: Appositions made by axons of descending interneurons in the guinea-pig small intestine, investigated by confocul microscopy. J. Chem. Neuroanat. 1997, 12, 151-164.
24. Matsuno, Y., N. Taira & T. Kadokawa: General pharmacological properties of AT-2266. Chemotherapy 1984, 23 (suppl. 3), 164-184.
25. Ministry of Health and Welfare, Pharmaceutical Affairs Bureau, Tokyo. Drug Side Effect Information No 81. Public notification, 1986.
26. Morikawa, K., S. Hashimoto, Y. Iwanaga, E. Makino & M. Yamazaki: General pharmacology of NY-198 II. Effects on the autonomic nervous system, peripheral nervous system and others. Chemotherapy 1988, 36 (suppl. 2), 284-299.
27. Mulholland, M. W. & D. M. Simeone: Prostaglandin E2 stimulation of acetylcholine release from guinea pig myenteric plexus neurons. Amer. J. Surg. 1993, 166, 552-556.
28. Neu, H. C. : Quinolone antimicrobial agents. Ann. Rev. Med. 1992, 43, 465-486.
29. Norrby, S. R.: Side-effects of quinolones: comparisons between quinolones and other antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 1991, 10, 378-383.
30. Ohkubo, H., M. Segawa, T. Hirayama & K. Nishino: Pharmacological studies on AM-715: (I) Influences of AM-715 on central nervous system, peripheral nervous system and smooth muscle organs. Chemotherapy 1981, 29 (suppl. 4), 965-984.
31. Paton, J. H. & D. S. Reeves: Fluroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs 1988, 36, 193-228.
32. Paton, J. H. & D. S. Reeves: Clinical features and management of adverse effects of quinolone antibacterials. Drug Safety 1991, 6, 8-27.
33. Sanders, K. M. & S. M. Ward: Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Amer. J. Physiol. 1992, 262, G379-G392.
34. Segev, S. M., M. Rehavi & E. Rubinstein: Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob. Agents Chemother. 1988, 32, 1624-1626.
35. Serio, R. & E. E. Daniel: Eicosanoids and peripheral neurotransmission. Prostagl. Leukotr. Essen Fatt Acids 1989, 38, 237-246.
36. Simpson, K. J. & M. J . Brodie: Convulsions related to enoxacin. Lancet 1985, ii, 161.
37. Suesa, N., M. F. Fernandez, M. Gutierrez, M. J. Rufat, E. Rotllan, L. Calvo, D. Mauleon & G. Carganico: Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen. Chirality 1993, 5, 589-595.
38. Takasuna, K., Y. Kasai, C. Usui, M. Takahashi, M. Hirohashi, K. Tamura & S. Takayama: General pharmacology of the new quinolone antibacterial agent levofloxacin. Arzneimittelforsch./Drug Res. 1992, 42, 408-418.
39. Takayama, S., M. Hirohashi, M. Kato & H. Shimada: Toxicity of quinolone antimicrobial agents. J. Toxicol. Environ. Health 1995, 45, 1-45.
40. Tonini, M., F. De Ponti: Serotonin modulation of gastrointestinal motility. In: Serotonin and gastrointestinal function. Eds.: T.S. Gaginella & J.J. Galligan. CRC Press, Boca Raton, Florida (USA) 1995, pp. 53-84.
41. A agonists on cholinergic neurons in the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 335, 629-635.
42. Tsuji, A., H. Sato, E. Okezaki, O. Nagata & H. Kato: Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of γ-aminobutyric acid binding to rat brain membrane in vitro. Biochem. Pharmacol. 1988, 37, 4408-4411.
43. Unseld, E., G. Ziegler, A. Gemeinhardt, U. Janssen & U. Klotz: Possible interaction of fluoroquinolones with the benzodiazepine-GABA-A-receptor complex. Brit. J. Clin. Pharmacol. 1990, 30, 63-70.
44. Waterman, S. A., M. Costa & M. Tonini: Accomodation mediated by enteric inhibitory reflexes in the isolated guinea-pig small intestine. J. Physiol. (Lond.) 1994, 474, 539-546.
45. Yamada, N., Y. Arai, K. Funayama, S. Kadowaki, K. Takahashi & K. Umezu: Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities. Arzneimittelforsch./Drug Res. 1995, 45, 33-35.
46. Yamamoto, K., H. Y. Naitoh, Y. Inoue & K. Yoshimura: Seizure discharges induced by the combination of a new quinolinecarboxylic acid antimicrobial drugs and non-steroidal anti-inflammatory drugs. Effect of NY-198 on the central nervous system. Chemotherapy 1988, 36 (suppl. 2), 300-324.